Medication Summary
No pharmacotherapeutic agents have been established as effective for the treatment of lipoid proteinosis.
Hamada T, McLean WH, Ramsay M, et al. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet. Apr 1 2002;11(7):833-40. [Medline].
Hamada T, Wessagowit V, South AP, Ashton GH, Chan I, Oyama N, et al. Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol. Mar 2003;120(3):345-50. [Medline].
Nasir M, Latif A, Ajmal M, Qamar R, Naeem M, Hameed A. Molecular analysis of lipoid proteinosis: identification of a novel nonsense mutation in the ECM1 gene in a Pakistani family. Diagn Pathol. Jul 26 2011;6:69. [Medline]. [Full Text].
Salih MA, Abu-Amero KK, Alrasheed S, Alorainy IA, Liu L, McGrath JA, et al. Molecular and neurological characterizations of three Saudi families with lipoid proteinosis. BMC Med Genet. Feb 24 2011;12:31. [Medline]. [Full Text].
Xu W, Wang L, Zhang L, Han D, Zhang L. Otolaryngological manifestations and genetic characteristics of lipoid proteinosis. Ann Otol Rhinol Laryngol. Nov 2010;119(11):767-71. [Medline].
Callizo M, Ibáñez-Flores N, Laue J, Cuadrado V, Graell X, Sancho JM. Eyelid lesions in lipoid proteinosis or Urbach-Wiethe disease: case report and review of the literature. Orbit. Oct 2011;30(5):242-4. [Medline].
Chan I, South AP, McGrath JA, Oyama N, Bhogal BS, Black MM, et al. Rapid diagnosis of lipoid proteinosis using an anti-extracellular matrix protein 1 (ECM1) antibody. J Dermatol Sci. Aug 2004;35(2):151-3. [Medline].
Kaya TI, Kokturk A, Tursen U, Ikizoglu G, Polat A. D-penicillamine treatment for lipoid proteinosis. Pediatr Dermatol. Jul-Aug 2002;19(4):359-62. [Medline].
Wong CK, Lin CS. Remarkable response of lipoid proteinosis to oral dimethyl sulphoxide. Br J Dermatol. Oct 1988;119(4):541-4. [Medline].
Dowlati A, Dowlati Y, Mansauri P, et al. Lipoid proteinosis and its response to etretinate therapy. In: Pierard GE, Pierard-Franchimont C, eds. The Dermis: From Biology to Disease. Paris, France: Monographies. Dermatopathologiques Liegoises; 1989:135-42.
Kroukamp G, Lehmann K. Treatment of laryngeal lipoid proteinosis using CO2 laser. S Afr Med J. Feb 2007;97(2):90, 92. [Medline].
Buchan NG, Kemble JV. Successful surgical treatment of lipoid proteinosis. Br J Dermatol. May 1974;90(5):561-6. [Medline].
Caccamo D, Jaen A, Telenta M, Varela E, Tiscornia O. Lipoid proteinosis of the small bowel. Arch Pathol Lab Med. May 1994;118(5):572-4. [Medline].
Caplan RM. Visceral involvement in lipoid proteinosis. Arch Dermatol. Feb 1967;95(2):149-55. [Medline].
Caro I. Lipoid proteinosis. Int J Dermatol. Jun 1978;17(5):388-93. [Medline].
Chan I, Liu L, Hamada T, Sethuraman G, McGrath JA. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol. Nov 2007;16(11):881-90. [Medline].
Emsley RA, Paster L. Lipoid proteinosis presenting with neuropsychiatric manifestations. J Neurol Neurosurg Psychiatry. Dec 1985;48(12):1290-2. [Medline].
Farolan MJ, Ronan SG, Solomon LM, Loeff DS. Lipoid proteinosis: case report. Pediatr Dermatol. Sep 1992;9(3):264-7. [Medline].
Fleischmajer R, Krieg T, Dziadek M, Altchek D, Timpl R. Ultrastructure and composition of connective tissue in hyalinosis cutis et mucosae skin. J Invest Dermatol. Mar 1984;82(3):252-8. [Medline].
Galadari I, Al-Kuwaiti R. Lipoid proteinosis: a case report. Int J Dermatol. May 2004;43(5):368-70. [Medline].
Hofer PA. Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae). A review. Acta Derm Venereol Suppl (Stockh). 1973;53:1-52. [Medline].
Holme SA, Lenane P, Krafchik BR. What syndrome is this? Urbach-Weithe syndrome (Lipoid proteinosis). Pediatr Dermatol. May-Jun 2005;22(3):266-7. [Medline].
Hu S, Kuo TT, Hong HS. Lipoid proteinosis: report of a possible localized form on both hands and wrists. Int J Dermatol. May 2005;44(5):408-10. [Medline].
Kaya TI, Tursen U, Kokturk A, Ikizoglu G, Dusmez D. The early erosive vesicular stage of lipoid proteinosis: clinical and histopathological features. Br J Dermatol. Feb 2003;148(2):380-2. [Medline].
Konstantinov K, Kabakchiev P, Karchev T, Kobayasi T, Ullman S. Lipoid proteinosis. J Am Acad Dermatol. Aug 1992;27(2 Pt 2):293-7. [Medline].
Kumar J, Ramesh V, Beena KR, Misra RS, Mukherjee A. Case 1: lipoid proteinosis (hyalinosis cutis et mucosae; Urbach-Wiethe disease). Clin Exp Dermatol. Sep 2002;27(6):531-2. [Medline].
Moy LS, Moy RL, Matsuoka LY, Ohta A, Uitto J. Lipoid proteinosis: ultrastructural and biochemical studies. J Am Acad Dermatol. Jun 1987;16(6):1193-201. [Medline].
Muda AO, Paradisi M, Angelo C, Mostaccioli S, Atzori F, Puddu P, et al. Lipoid proteinosis: clinical, histologic, and ultrastructural investigations. Cutis. Oct 1995;56(4):220-4. [Medline].
Navarro C, Fachal C, Rodríguez C, Padró L, Domínguez C. Lipoid proteinosis. A biochemical and ultrastructural investigation of two new cases. Br J Dermatol. Aug 1999;141(2):326-31. [Medline].
Ozbek SS, Akyar S, Turgay M. Case report: computed tomography findings in lipoid proteinosis: report of two cases. Br J Radiol. Feb 1994;67(794):207-9. [Medline].
Ozkaya-Bayazit E, Ozarmagan G, Baykal C, Ulug T. [Oral DMSO therapy in 3 patients with lipoidproteinosis. Results of long-term therapy]. Hautarzt. Jul 1997;48(7):477-81. [Medline].
Ringpfeil F. Selected disorders of connective tissue: pseudoxanthoma elasticum, cutis laxa, and lipoid proteinosis. Clin Dermatol. Jan-Feb 2005;23(1):41-6. [Medline].
Teive HA, Pereira ER, Zavala JA, Lange MC, de Paola L, Raskin S, et al. Generalized dystonia and striatal calcifications with lipoid proteinosis. Neurology. Dec 14 2004;63(11):2168-9. [Medline].
Touart DM, Sau P. Cutaneous deposition diseases. Part I. J Am Acad Dermatol. Aug 1998;39(2 Pt 1):149-71; quiz 172-4. [Medline].

